Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

DexCom Inc (NASDAQ:DXCM) is facing renewed scrutiny after three people with diabetes reportedly died following issues with its G7 continuous glucose monitor, according to adverse event filings submitted to the Food and Drug Administration in September.

Benzinga

7 Medications Pulled for Links to Devastating Outcomes

We like to believe the pills prescribed to us are perfectly safe—that each one has passed through rigorous testing, expert oversight, and endless studies. And for the most part, that’s true. But every now and then, history reminds us that even modern medicine can stumble spectacularly. Some drugs once hailed…

Everybody Loves Your Money

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) on Tuesday reported third-quarter adjusted earnings of $11.83 per share, down 5% year-over-year, beating the consensus of $9.59.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Under-the-Radar Biotech Stocks That Could Soar in 2026

These smaller innovators are quietly advancing promising therapies that could unlock their true potential.

Barchart

A New Hair Loss Medication, VDPHL01, Could Soon Hit the Market

Here's what the pros have to say about VDPHL01.

Marie Claire

8 Pharmacy Shelves That Stock Identical Generics Cheaper

Grocery Coupon Guide

‘A medical miracle’: is period blood ‘the most overlooked opportunity’ in women’s health?

Period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions – including difficult-to-diagnose endometriosis

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Australia must ‘step up to prevent catastrophic and preventable loss of life’ amid Trump cuts, former CDC boss says

Dr Tom Frieden served as director of the US health body under Barack Obama until 2017 and warns about cuts under Donald Trump

The Guardian - AU

Atorvastatin Recall 2025 Explained: What the Drug Is, Which Products Are Impacted and What Patients Should Do

The FDA recalls over 140,000 bottles of Atorvastatin after failed quality tests. Find out which products are affected and what patients should do next.

International Business Times UK

FDA approves new pill for menopausal women to treat hot flashes and night sweats

Lynkuet was approved by the FDA Friday to treat moderate-to-severe hot flashes and night sweats

The Independent UK

Check your cabinets: More than 140,000 bottles of cholesterol medication part of elevated recall over health risk

The tablets were distributed nationwide in up to 1,000-count bottles

The Independent UK

Biogen's Immunology Pipeline Has Long-Term Potential: Analyst

On Friday, Biogen Inc. (NASDAQ:BIIB) and Vanqua Bio announced a license agreement granting Biogen exclusive worldwide rights to Vanqua's preclinical, oral C5aR1 antagonist. The agreement strengthens Biogen's immunology.

Benzinga

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

Sanofi SA (NASDAQ:SNY) reported third-quarter sales of $14.55 billion (12.43 billion euros), beating the consensus of $14.46 billion. Sales increased 2.3% year over year, up 7% in constant currency.

Benzinga

FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep

On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Everybody Loves Your Money

7 FDA Approvals That Should Never Have Happened

Every time you see the words “FDA approved,” it’s supposed to mean safety, science, and trust. After all, the Food and Drug Administration is the final checkpoint before a product reaches your medicine cabinet, right? But history says otherwise. Over the years, some truly shocking—and sometimes disastrous—products have slipped through…

International Business Times

Neutrogena Issues Recall of Makeup Wipes That Tested Positive for Harmful Bacteria

Neutrogena recalls makeup wipes after tests found harmful bacteria, urging consumers to stop use immediately.

Benzinga

Intel, Scienture Holdings, Ford, Deckers, And Super Micro Computer: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,734.61, the SP 500 advancing nearly 0.6% to 6,738.44, and the Nasdaq climbing about 0.9% to 22,941.79.These are the top stocks that gained the attention of retail traders and investors through the day: Intel…

Grocery Coupon Guide

9 OTC Cold Remedies That Don’t Work as Advertised

When you have a cold, you will do almost anything to feel better fast. The pharmacy aisle is filled with over-the-counter (OTC) remedies that promise quick relief from your symptoms. However, many of these popular products make claims that are not supported by strong scientific evidence. While they may offer…

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Three Coke products all under recall for ‘foreign material’ inside the cans

Coca-Cola and the FDA say they have not received any reports of consumers being injured by the recalled Coke and Sprite cans

The Independent UK

More shrimp recalled over possible radioactive contamination. See the full list of stores and states

Some of the shrimp have been sold at Publix stores in eight states

Barchart

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.

Benzinga

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz

On Wednesday, Alkermes plc (NASDAQ:ALKS) agreed to acquire Avadel Pharmaceuticals plc (NASDAQ:AVDL) for up to $20 per share in cash, which values Avadel at approximately $2.1 billion.

Roll Call

Trump’s approach to lowering drug costs is raising questions - Roll Call

Several drug pricing experts say without key details, it’s hard to call the individual pharma deals a win for the Trump administration.

Benzinga

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding to support development of roluperidone for schizophrenia.

Fortune

Gen Zers are turning to frozen food to stretch their budgets and they don’t feel good about it

Somehow, the generation most skeptical about frozen food’s nutrition, quality, and safety is the one that's most been forced into its frosty arms.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.